• Private Equity Firm

    Shavit Capital is an investment firm that specializes in late-stage investments in Israeli companies.

    Shavit Capital has over $200 million under management across four separate private equity funds. Shavit Capital was founded in 2008 and the fourth fund was raised in 2017.  These Funds invest in Israeli companies with proven technologies, products, markets and strong management teams. The Funds invest in equity mezzanine or bridge rounds in companies which subsequently expect to raise relatively larger amounts pursuant to an IPO on a major international public exchange or a dual listing of a company that trades on the Tel Aviv Stock Exchange.

    Shavit Capital also invests in other late-stage opportunities, especially through PIPEs (Private Investment in Public Equites) of Israeli publicly-traded companies.

  • Company News

    Gamida Cell reports positive cancer drug trial
    December 13, 2017
    Pharma Veteran Julian Adams takes Helm at Gamida Cell
    November 21, 2017
    Gamida Cell Appoints Julian Adams, Ph.D., Chairman and Chief Executive Office
    November 20, 2017
    Positive Phase II results for Mapi Pharma's lead product
    November 1, 2017
    Gamida Announces 1st Patient Transplanted in Phase 1/2 Study for Severe Aplas
    August 21, 2017
    Mapi Pharma raises $10m
    August 17, 2017
    Intec Announces Pricing of $50m Public Offering of Ordinary Shares
    August 16, 2017
    Foamix Announces Dosing of First Patient in Third Phase 3 Acne Study
    August 3, 2017
    Gamida in flurry of activity as hope nears for bone marrow patients
    August 3, 2017
    Intec Reports Clinical Results From Phase I Trial of Accordion Pill for Canna
    August 3, 2017